Holding(s) in Company
24 September 2005 - 2:35AM
UK Regulatory
RNS Number:7094R
Cambridge Antibody Tech Group PLC
23 September 2005
NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Name of company
Cambridge Antibody Technology Group plc
2. Name of shareholder having a major interest
Franklin Resources Inc.
3. Please state whether notification indicates that it is in respect of holding
of the shareholder named in 2 above or in respect of a non-beneficial interest
or in the case of an individual holder if it is a holding of that person's
spouse or children under the age of 18
Bank of New York non beneficial
JP Morgan Chase Bank non beneficial
Citibank Nominees Limited non beneficial
State Street Bank non beneficial
4. Name of the registered holder(s) and, if more than one holder, the number of
shares held by each of them
Bank of New York 22,229
JP Morgan Chase Bank 1,250,546
Citibank Nominees Limited 13,000
State Street Bank 283,314
5. Number of shares / amount of stock acquired
not disclosed
6. Percentage of issued class
not known
7. Number of shares / amount of stock disposed
None
8. Percentage of issued class
N/A
9. Class of security
Ordinary 10 pence shares
10. Date of transaction
Not disclosed
11. Date company informed
23 September 2005
12. Total holding following this notification
1,569,089
13. Total percentage holding of issued class following this notification
3.0385%
14. Any additional information
The disclosure has been made on behalf of Franklin Resources, Inc and its
affiliates which includes Franklin Mutual Advisers, LLC and Templeton Worldwide,
Inc. Franklin Resources, Inc and its affiliates perform investment management
advisory and related services for clients on a global basis.
15. Name of contact and telephone number for queries
Justin Hoskins 01223 898589
16. Name and signature of authorised company official responsible for making
this notification
Justin Hoskins, Company Secretary
Date of notification
23 September 2005
The FSA does not give any express or implied warranty as to the accuracy of this
document or material and does not accept any liability for error or omission.
The FSA is not liable for any damages (including, without limitation, damages
for loss of business or loss of profits) arising in contract, tort or otherwise
from the use of or inability to use this document, or any material contained in
it, or from any action or decision taken as a result of using this document or
any such material.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEAKNDADFSEFE
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Sep 2024 to Oct 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Oct 2023 to Oct 2024